PodParley PodParley
PodParley
Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness episode artwork

EPISODE · May 7, 2021 · 18 MIN

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

from HCPLive Podcasts · host HCPLive.com

Dr. Paul Yang, of Casey Eye Institute, joins to discuss new ARVO 2021 data supporting the gene therapy for X-linked retinitis pigmentosa.

Episode metadata supplied by the publisher feed · Published May 7, 2021

Embed this episode

NOW PLAYING

Gene Therapy AGTC-501 Hits Phase 1/2 Marks for Rare Pediatric Blindness

0:00 18:31

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of HCPLive Podcasts?

This episode is 18 minutes long.

When was this HCPLive Podcasts episode published?

This episode was published on May 7, 2021.

Can I download this HCPLive Podcasts episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!